PHA-Exchange> Novartis targets India's Patents Act (ii) Thailand and Philippines push generic drugs

[Claudio]

From: Third World Network 
www.twnside.org.sg
 

 

Novartis targets India's Patents Act

 

India could dry up as a source of newer and future affordable medicines if Novartis succeeds in its challenge against India's Patent act. Medecins sans Frontiers has launched an international petition to urge Novartis to immediately drop the case 

(for further information visit www.accessmed-msf.org).

 

India is one of the most vital sources of generic drugs and Novartis' attack on India's patent law could have disastrous consequences on access to affordable medicines for millions of people in the developing world.

 

Thailand and Philippines push generic drugs

 

Meanwhile Thailand and the Philippines are pushing ahead with plans to provide cheaper generic drugs despite threats from Big Pharma. 

See South-North Development Monitor (SUNS) # 6167, 21 December 2006 and # 6165, 19 December 2006.

 


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20070111/c07c0416/attachment-0001.html>